NATH BIOGENES (INDIA)
Back to Income Statement
|
NATH BIOGENES (INDIA) Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹50 Cr | ₹50 Cr | ₹49 Cr | ₹37 Cr | ₹20 Cr |
What is the latest Operating Profit of NATH BIOGENES (INDIA) ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹50 Cr |
| Mar2024 | ₹50 Cr |
| Mar2023 | ₹49 Cr |
| Mar2022 | ₹37 Cr |
| Mar2013 | ₹20 Cr |
How is Operating Profit of NATH BIOGENES (INDIA) Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹50 Cr | 0.02 | |
| Mar2024 | ₹50 Cr | 1.99 | |
| Mar2023 | ₹49 Cr | 31.59 | |
| Mar2022 | ₹37 Cr | 87.05 | |
| Mar2013 | ₹20 Cr | - | |
Compare Operating Profit of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹275.7 Cr | 2.1% | -5.7% | -1% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹10,949.0 Cr | -3.1% | -12.1% | -10.3% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,119.2 Cr | 9.6% | -8.6% | -24.3% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,767.5 Cr | -2.2% | -13.3% | -21.5% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹885.6 Cr | 0% | -10% | -38% | Stock Analytics | |
| INDO US BIOTECH | ₹198.5 Cr | -27.4% | -25.7% | -47.8% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | 2.1% |
-5.7% |
-1% |
| SENSEX | -5% |
-9.6% |
3.1% |
You may also like the below Video Courses